Department of Biotechnology, Faculty of Biological Science, Alzahra University, Tehran, Iran.
Department of Energy and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran.
Appl Environ Microbiol. 2020 May 5;86(10). doi: 10.1128/AEM.00367-20.
A longstanding awareness in generating resistance to common antimicrobial therapies by Gram-negative bacteria has made them a major threat to global health. The application of antimicrobial peptides as a therapeutic agent would be a great opportunity to combat bacterial diseases. Here, we introduce a new antimicrobial peptide (∼8.3 kDa) from probiotic strain ATCC 4356, designated acidocin 4356 (ACD). This multifunctional peptide exerts its anti-infective ability against through an inhibitory action on virulence factors, bacterial killing, and biofilm degradation. Reliable performance over tough physiological conditions and low hemolytic activity confirmed a new hope for the therapeutic setting. Antibacterial kinetic studies using flow cytometry technique showed that the ACD activity is related to the change in permeability of the membrane. The results obtained from molecular dynamic (MD) simulation were perfectly suited to the experimental data of ACD behavior. The structure-function relationship of this natural compound, along with the results of transmission electron microscopy analysis and MD simulation, confirmed the ability of the ACD aimed at enhancing bacterial membrane perturbation. The peptide was effective in the treatment of infection in mouse model. The results support the therapeutic potential of ACD for the treatment of infections. Multidrug-resistant bacteria are a major threat to global health, and the bacterium with the ability to form biofilms is considered one of the main causative agents of nosocomial infections. Traditional antibiotics have failed because of increased resistance. Thus, finding new biocompatible antibacterial drugs is essential. Antimicrobial peptides are produced by various organisms as a natural defense mechanism against pathogens, inspiring the possible design of the next generation of antibiotics. In this study, a new antimicrobial peptide was isolated from ATCC 4356, counteracting both biofilm and planktonic cells of A detailed investigation was then conducted concerning the functional mechanism of this peptide by using fluorescence techniques, electron microscopy, and methods. The antibacterial and antibiofilm properties of this peptide may be important in the treatment of infections.
革兰氏阴性菌对常见抗菌疗法产生耐药性的长期意识,使其成为全球健康的主要威胁。将抗菌肽作为治疗剂的应用将是对抗细菌疾病的绝佳机会。在这里,我们介绍一种来自益生菌菌株 ATCC 4356 的新型抗菌肽(~8.3 kDa),命名为嗜酸菌素 4356(ACD)。这种多功能肽通过抑制毒力因子、杀菌和生物膜降解来发挥其抗感染能力。在苛刻的生理条件下可靠的性能和低溶血活性证实了治疗环境的新希望。使用流式细胞术技术进行的抗菌动力学研究表明,ACD 的活性与膜通透性的变化有关。分子动力学(MD)模拟得到的结果与 ACD 行为的实验数据完全吻合。该天然化合物的结构-功能关系,以及透射电子显微镜分析和 MD 模拟的结果,证实了 ACD 增强细菌膜扰动的能力。该肽在小鼠模型中的 感染治疗中有效。这些结果支持 ACD 治疗 感染的治疗潜力。多药耐药菌对全球健康构成重大威胁,能够形成生物膜的 菌被认为是医院获得性感染的主要病原体之一。由于耐药性增加,传统抗生素已失效。因此,寻找新的生物相容性抗菌药物至关重要。抗菌肽是各种生物体作为对抗病原体的天然防御机制产生的,激发了下一代抗生素的可能设计。在这项研究中,从 ATCC 4356 中分离出一种新型抗菌肽,对抗 生物膜和浮游细胞都有作用。然后通过荧光技术、电子显微镜和 MD 方法对该肽的功能机制进行了详细研究。该肽的抗菌和抗生物膜特性在治疗 感染中可能很重要。